316 related articles for article (PubMed ID: 17768685)
1. Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas.
Gong J; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Lopes MB; Hussaini IM; Laws ER
Pituitary; 2008; 11(1):37-48. PubMed ID: 17768685
[TBL] [Abstract][Full Text] [Related]
2. [Expression of MMPPs and TIMP and invasiveness in pituitary adenomas].
Wang J; Liu YS
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):647-50. PubMed ID: 16114548
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase 2 and 9 expression correlated with cavernous sinus invasion of pituitary adenomas.
Liu W; Matsumoto Y; Okada M; Miyake K; Kunishio K; Kawai N; Tamiya T; Nagao S
J Med Invest; 2005 Aug; 52(3-4):151-8. PubMed ID: 16167532
[TBL] [Abstract][Full Text] [Related]
4. Role of matrix metalloproteinase 9 in pituitary tumor behavior.
Turner HE; Nagy Z; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Aug; 85(8):2931-5. PubMed ID: 10946906
[TBL] [Abstract][Full Text] [Related]
5. Regulating effect of MMP-9 and TIMP-1 in pituitary adenoma invasion.
Mao JH; Guo H; Si N; Qiu L; Guo LF; Sun ZS; Xiang Y; Yang XH; Zhao WG; Zhang WC
Genet Mol Res; 2015 Dec; 14(4):17091-8. PubMed ID: 26681056
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-2: Prognostic biological markers in invasive prolactinomas.
Gültekin GD; Çabuk B; Vural Ç; Ceylan S
J Clin Neurosci; 2015 Aug; 22(8):1282-7. PubMed ID: 26071077
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line.
Hussaini IM; Trotter C; Zhao Y; Abdel-Fattah R; Amos S; Xiao A; Agi CU; Redpath GT; Fang Z; Leung GK; Lopes MB; Laws ER
Am J Pathol; 2007 Jan; 170(1):356-65. PubMed ID: 17200207
[TBL] [Abstract][Full Text] [Related]
8. EZH2 upregulation correlates with tumor invasiveness, proliferation, and angiogenesis in human pituitary adenomas.
Liu B; Pang B; Wang Q; Yang S; Gao T; Ding Q; Liu H; Yang Y; Fan H; Zhang R; Xin T; Xu G; Pang Q
Hum Pathol; 2017 Aug; 66():101-107. PubMed ID: 28666925
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase-2 expression correlates with cavernous sinus invasion in pituitary adenomas.
Liu W; Kunishio K; Matsumoto Y; Okada M; Nagao S
J Clin Neurosci; 2005 Sep; 12(7):791-4. PubMed ID: 16198918
[TBL] [Abstract][Full Text] [Related]
10. Metalloproteinases ADAM12 and MMP-14 are associated with cavernous sinus invasion in pituitary adenomas.
Wang J; Voellger B; Benzel J; Schlomann U; Nimsky C; Bartsch JW; Carl B
Int J Cancer; 2016 Sep; 139(6):1327-39. PubMed ID: 27144841
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 and -2 and tissue inhibitor of matrix metalloproteinase-2 in invasive pituitary adenomas: A systematic review and meta-analysis of case-control trials.
Liu HY; Gu WJ; Wang CZ; Ji XJ; Mu YM
Medicine (Baltimore); 2016 Jun; 95(24):e3904. PubMed ID: 27310993
[TBL] [Abstract][Full Text] [Related]
12. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
13. Expressions of Matrix Metalloproteinases-9 and Tissue Inhibitor of Metalloproteinase-1 in Pituitary Adenomas and Their Relationships with Prognosis.
Guo H; Sun Z; Wei J; Xiang Y; Qiu L; Guo L; Zhao W; Xu Z; Mao J
Cancer Biother Radiopharm; 2019 Feb; 34(1):1-6. PubMed ID: 30676069
[TBL] [Abstract][Full Text] [Related]
14. The Clinical Utility of TIMP3 Expression in ACTH-Secreting Pituitary Tumor.
Sun B; Liu X; Yang Y; Dai C; Li Y; Jiao Y; Wei Z; Yao Y; Feng M; Bao X; Deng K; Wang N; Wang R
J Mol Neurosci; 2016 Jan; 58(1):137-44. PubMed ID: 26676407
[TBL] [Abstract][Full Text] [Related]
15. Expression of cold-inducible RNA-binding protein (CIRP) in pituitary adenoma and its relationships with tumor recurrence.
Wang M; Zhang H; Heng X; Pang Q; Sun A
Med Sci Monit; 2015 May; 21():1256-60. PubMed ID: 25934796
[TBL] [Abstract][Full Text] [Related]
16. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
[TBL] [Abstract][Full Text] [Related]
17. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
[TBL] [Abstract][Full Text] [Related]
18. Identification of a subtype-specific ENC1 gene related to invasiveness in human pituitary null cell adenoma and oncocytomas.
Feng J; Hong L; Wu Y; Li C; Wan H; Li G; Sun Y; Yu S; Chittiboina P; Montgomery B; Zhuang Z; Zhang Y
J Neurooncol; 2014 Sep; 119(2):307-15. PubMed ID: 24916845
[TBL] [Abstract][Full Text] [Related]
19. Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion.
Trouillas J; Daniel L; Guigard MP; Tong S; Gouvernet J; Jouanneau E; Jan M; Perrin G; Fischer G; Tabarin A; Rougon G; Figarella-Branger D
J Neurosurg; 2003 May; 98(5):1084-93. PubMed ID: 12744370
[TBL] [Abstract][Full Text] [Related]
20. Expression of E-cadherin, Slug and NCAM and its relationship to tumor invasiveness in patients with acromegaly.
Mendes GA; Haag T; Trott G; Rech CGSL; Ferreira NP; Oliveira MC; Kohek MB; Pereira-Lima JFS
Braz J Med Biol Res; 2017 Dec; 51(2):e6808. PubMed ID: 29267504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]